A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry

Archive ouverte

Schwantes-An, Tae-Hwi | Whitfield, John | Aithal, Guruprasad P. | Atkinson, Stephen R | Bataller, Ramon | Botwin, Greg | Chalasani, Naga P | Cordell, Heather | Daly, Ann K. | Darlay, Rebecca | Day, Christopher P. | Eyer, Florian | Foroud, Tatiana | Gawrieh, Samer | Gleeson, Dermot | Goldman, David | Haber, Paul S | Jacquet, Jean-Marc | S. Lammert, Craig | Liang, Tiebing | Liangpunsakul, Suthat | Masson, Steven | Mathurin, Philippe | Moirand, Romain | Mcquillin, Andrew | Moreno, Christophe | Morgan, Marsha y | Mueller, Sebastian | Müllhaupt, Beat | Nagy, Laura | Nahon, Pierre | Nalpas, Bertrand | Naveau, Sylvie | Perney, Pascal | Pirmohamed, Munir | Seitz, Helmut K. | Soyka, Michael | Stickel, Felix | Thompson, Andrew | Thursz, Mark R | Trépo, Eric | Morgan, Timothy, R. | Seth, Devanshi

Edité par CCSD ; John Wiley & Sons Inc -

International audience. Background: Polygenic Risk Scores (PRS) based on results from genome-wide association studies offer the prospect of risk stratification for many common and complex diseases. We developed a PRS for alcohol-associated cirrhosis by comparing single-nucleotide polymorphisms among patients with alcohol-associated cirrhosis (ALC) versus drinkers who did not have evidence of liver fibrosis/cirrhosis.Methods: Using a data-driven approach, a PRS for ALC was generated using a meta-genome-wide association study of ALC (N=4305) and an independent cohort of heavy drinkers with ALC and without significant liver disease (N=3037). It was validated in 2 additional independent cohorts from the UK Biobank with diagnosed ALC (N=467) and high-risk drinking controls (N=8981) and participants in the Indiana Biobank Liver cohort with alcohol-associated liver disease (N=121) and controls without liver disease (N=3239).Results: A 20-single-nucleotide polymorphisms PRS for ALC (PRSALC) was generated that stratified risk for ALC comparing the top and bottom deciles of PRS in the 2 validation cohorts (ORs: 2.83 [95% CI: 1.82 -4.39] in UK Biobank; 4.40 [1.56 -12.44] in Indiana Biobank Liver cohort). Furthermore, PRSALC improved the prediction of ALC risk when added to the models of clinically known predictors of ALC risk. It also stratified the risk for metabolic dysfunction -associated steatotic liver disease -cirrhosis (3.94 [2.23 -6.95]) in the Indiana Biobank Liver cohort -based exploratory analysis.Conclusions: PRSALC incorporates 20 single-nucleotide polymorphisms, predicts increased risk for ALC, and improves risk stratification for ALC compared with the models that only include clinical risk factors. This new score has the potential for early detection of heavy drinking patients who are at high risk for ALC.

Suggestions

Du même auteur

A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers

Archive ouverte | Whitfield, John B | CCSD

International audience. Background & aims - Only a minority of excess alcohol drinkers develop cirrhosis. We developed and evaluated risk stratification scores to identify those at highest risk. Methods - Three coh...

Genome-wide association study and meta-analysis on alcohol-related liver cirrhosis identifies novel genetic risk factors

Archive ouverte | Schwantes-An, Tae-Hwi | CCSD

International audience. Background and aims - Only a minority of heavy drinkers progress to alcohol-associated cirrhosis (ALC). The aim of this study was to identify common genetic variants that underlie risk for AL...

CAN GENOTYPING PREDICT RISK OF ALCOHOL-RELATED CIRRHOSIS IN HIGH-RISK DRINKERS?

Archive ouverte | Whitfield, John | CCSD

International audience

Chargement des enrichissements...